|
|
|
Insider
Information: |
Fuchs Henry J |
Relationship: |
|
City: |
Palo Alto |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
5 |
|
Direct
Shares |
222,228 |
|
Indirect Shares
|
0 |
|
|
Direct
Value |
$18,063,061 |
|
|
Indirect Value
|
$0 |
|
|
Total
Shares |
222,228 |
|
|
Total
Value |
$18,063,061 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Onyx Pharmaceuticals Inc |
ONXX |
EVP & Chief Medical Of... |
2008-11-18 |
14,891 |
2006-05-15 |
0 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director |
2012-06-19 |
0 |
2007-12-05 |
0 |
Premium* |
|
Biomarin Pharmaceutical Inc |
BMRN |
President, Worldwide R&D |
2024-03-15 |
196,872 |
2009-03-02 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director |
2019-11-08 |
0 |
2014-04-01 |
0 |
Premium* |
|
Mirati Therapeutics, Inc. |
MRTX |
|
2023-01-20 |
10,465 |
2020-01-03 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
294 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 8 of 12
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-06-01 |
4 |
AS |
$35.02 |
$175,078 |
D/D |
(5,000) |
52,277 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2016-01-01 |
4 |
A |
$35.20 |
$9,997 |
D/D |
284 |
2,841 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-06-23 |
4 |
AS |
$35.30 |
$220,625 |
D/D |
(6,250) |
16,975 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-02-19 |
4 |
AS |
$35.67 |
$37,168 |
D/D |
(1,042) |
15,208 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-05-16 |
4 |
AS |
$35.80 |
$936,311 |
D/D |
(26,041) |
16,975 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-05-29 |
4 |
S |
$35.90 |
$897,663 |
D/D |
(25,000) |
16,975 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-11-01 |
4 |
AS |
$37.08 |
$185,384 |
D/D |
(5,000) |
52,277 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-09-15 |
4 |
AS |
$37.32 |
$233,250 |
D/D |
(6,250) |
15,933 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
President, Worldwide R&D |
|
2017-06-19 |
4 |
OE |
$37.46 |
$22,588 |
D/D |
603 |
137,025 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-09-04 |
4 |
AS |
$37.76 |
$188,791 |
D/D |
(5,000) |
52,277 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2007-08-30 |
4 |
S |
$38.19 |
$956,260 |
D/D |
(25,000) |
17,292 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-08-01 |
4 |
AS |
$38.63 |
$193,145 |
D/D |
(5,000) |
52,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-10-01 |
4 |
AS |
$39.75 |
$198,760 |
D/D |
(5,000) |
52,277 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-07-02 |
4 |
AS |
$40.00 |
$602,808 |
D/D |
(15,000) |
52,277 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-08-14 |
4 |
S |
$40.94 |
$1,050,139 |
D/D |
(25,000) |
16,975 |
0 |
- |
|
ONXX |
Onyx Pharmaceuticals Inc |
EVP & Chief Medical Officer |
|
2008-08-19 |
4 |
AS |
$43.57 |
$45,400 |
D/D |
(1,042) |
15,933 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2012-11-05 |
4 |
AS |
$46.00 |
$460,000 |
D/D |
(10,000) |
52,277 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2018-07-01 |
4 |
A |
$50.40 |
$9,979 |
D/D |
198 |
6,035 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2015-04-30 |
4 |
A |
$51.26 |
$73,050 |
D/D |
1,425 |
90,060 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2016-04-29 |
4 |
A |
$51.26 |
$21,275 |
D/D |
415 |
121,081 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-08 |
4 |
D |
$56.78 |
$143,142 |
D/D |
(2,521) |
71,329 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-16 |
4 |
S |
$56.86 |
$105,994 |
D/D |
(1,864) |
60,950 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-15 |
4 |
D |
$57.44 |
$116,948 |
D/D |
(2,036) |
62,814 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-09 |
4 |
S |
$57.91 |
$201,474 |
D/D |
(3,479) |
67,850 |
0 |
- |
|
BMRN |
Biomarin Pharmaceutical I... |
EVP, Chief Medical Officer |
|
2014-05-13 |
4/A |
S |
$58.23 |
$83,498 |
D/D |
(1,434) |
63,415 |
0 |
- |
|
294 Records found
|
|
Page 8 of 12 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|